Nu-Med Plus (NUMD) Common Equity (2011 - 2025)
Nu-Med Plus (NUMD) reported Common Equity of -$271278.0 for Q4 2025, down 26.12% on a YoY basis from -$367184.8 in Q4 2024, and down 4.88% sequentially from -$258660.0 in Q3 2025.
Nu-Med Plus (NUMD) Common Equity (2011 - 2025) Analysis & Trends
Nu-Med Plus (NUMD) has 15 years of Common Equity data on file, last reported at -$271278.0 in Q4 2025.
- For the quarter ending Q4 2025, Common Equity fell 26.12% year-over-year to -$271278.0; the trailing twelve-month figure through Dec 2025 stood at -$271278.0 (down 26.12% YoY), and the FY2025 full-year result was -$271278.0, down 26.12% from the prior year.
- Common Equity declined to -$271278.0 in Q4 2025, from -$258660.0 in the prior quarter.
- In the past five years, Common Equity ranged from a high of $190955.0 in Q1 2021 to a low of -$271278.0 in Q4 2025.
- A 5-year average of -$152677.1 and a median of -$177220.5 in 2024 frame the typical range for Common Equity.
- Across the five-year window, Common Equity jumped 151.99% in 2021 and tumbled 14865.54% in 2022, its largest moves.
- Tracing NUMD's Common Equity over 5 years: stood at -$132358.0 in 2021, then jumped by 52.38% to -$63025.0 in 2022, then plunged by 132.85% to -$146751.0 in 2023, then sank by 46.57% to -$215096.0 in 2024, then retreated by 26.12% to -$271278.0 in 2025.
- Business Quant data shows NUMD's Common Equity at -$271278.0 in Q4 2025, -$258660.0 in Q3 2025, and -$246694.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 52.70 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 38.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 50.07 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 25.86 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 10.33 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.96 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 13.34 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.67 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 5.29 Bn |
| 10 | Nu-Med Plus | 1.67 Mn | 1.67 Mn | - | -271,278.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -271,278.00 |
| Sep 30, 2025 | -258,660.00 |
| Jun 30, 2025 | -246,694.00 |
| Mar 31, 2025 | -235,029.00 |
| Dec 31, 2024 | -215,096.00 |
| Sep 30, 2024 | -204,541.00 |
| Jun 30, 2024 | -185,864.00 |
| Mar 31, 2024 | -168,577.00 |
| Dec 31, 2023 | -146,751.00 |
| Sep 30, 2023 | -131,955.00 |
| Jun 30, 2023 | -115,549.00 |
| Mar 31, 2023 | -91,229.00 |
| Dec 31, 2022 | -63,025.00 |
| Sep 30, 2022 | -270,131.00 |
| Jun 30, 2022 | -247,081.00 |
| Mar 31, 2022 | -189,011.00 |
| Dec 31, 2021 | -132,358.00 |
| Sep 30, 2021 | -70,017.00 |
| Jun 30, 2021 | -1,651.00 |
| Mar 31, 2021 | 190,955.00 |